Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$77.98
-2.78-3.44%
al cierre: -
$78.19
0.210.27%
After hour: 6:04 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Albemarle Corp ha un obiettivo di prezzo di consenso pari a $101.48, stabilito in base alle ultime valutazioni degli analisti di 27. Le ultime 3 valutazioni degli analisti sono state rilasciate da Scotiabank, Wells Fargo y UBS il agosto 1, 2025, agosto 1, 2025 y julio 31, 2025. Con un obiettivo di prezzo medio di $67.33 tra le Scotiabank, Wells Fargo y UBS, c'è un implicito -13.88% downside per Albemarle Corp da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Scotiabank
Wells Fargo
UBS
Baird
Keybanc
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Albemarle
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/01/2025 | -10.47% | Scotiabank | $65 → $70 | Maintains | Sector Perform | |||
08/01/2025 | -10.47% | Wells Fargo | $75 → $70 | Maintains | Equal-Weight | |||
07/31/2025 | -20.71% | UBS | $57 → $62 | Maintains | Sell | |||
07/30/2025 | — | Keybanc | — | Downgrade | Overweight → Sector Weight | |||
07/29/2025 | -23.26% | Baird | $60 → $60 | Downgrade | Neutral → Underperform | |||
07/14/2025 | -4.08% | Wells Fargo | $60 → $75 | Maintains | Equal-Weight | |||
07/14/2025 | 11.27% | Keybanc | $95 → $87 | Maintains | Overweight | |||
07/11/2025 | -27.1% | UBS | $64 → $57 | Downgrade | Neutral → Sell | |||
05/06/2025 | -16.87% | Scotiabank | $75 → $65 | Maintains | Sector Perform | |||
05/06/2025 | -25.82% | Morgan Stanley | $68 → $58 | Maintains | Underweight | |||
05/06/2025 | -23.26% | JP Morgan | $80 → $60 | Maintains | Neutral | |||
05/02/2025 | 21.5% | Keybanc | $102 → $95 | Maintains | Overweight | |||
05/01/2025 | -16.87% | TD Securities | $115 → $65 | Maintains | Hold | |||
04/15/2025 | -18.15% | Citigroup | $85 → $64 | Maintains | Neutral | |||
04/15/2025 | -23.26% | Baird | $77 → $60 | Maintains | Neutral | |||
04/14/2025 | 30.45% | Keybanc | $122 → $102 | Maintains | Overweight | |||
04/14/2025 | -16.87% | Truist Securities | $85 → $65 | Maintains | Hold | |||
04/09/2025 | -23.26% | Wells Fargo | $80 → $60 | Maintains | Equal-Weight | |||
04/07/2025 | -18.15% | UBS | $86 → $64 | Maintains | Neutral | |||
03/07/2025 | 8.71% | Mizuho | $90 → $85 | Maintains | Neutral | |||
02/20/2025 | 8.71% | Piper Sandler | $90 → $85 | Maintains | Underweight | |||
02/18/2025 | -13.03% | Morgan Stanley | $73 → $68 | Maintains | Underweight | |||
02/18/2025 | -4.08% | Scotiabank | $85 → $75 | Maintains | Sector Perform | |||
02/14/2025 | 56.03% | Keybanc | $127 → $122 | Maintains | Overweight | |||
02/14/2025 | 8.71% | Truist Securities | $96 → $85 | Maintains | Hold | |||
02/13/2025 | 9.99% | UBS | $99 → $86 | Maintains | Neutral | |||
01/28/2025 | 22.78% | Truist Securities | → $96 | Initiates | → Hold | |||
01/10/2025 | 26.61% | UBS | $108 → $99 | Maintains | Neutral | |||
01/07/2025 | 34.29% | Mizuho | $110 → $105 | Maintains | Neutral | |||
12/18/2024 | 31.73% | Baird | $79 → $103 | Maintains | Neutral | |||
11/12/2024 | 70.1% | RBC Capital | $108 → $133 | Maintains | Outperform | |||
11/12/2024 | 62.42% | Keybanc | $132 → $127 | Maintains | Overweight | |||
11/08/2024 | 117.42% | Oppenheimer | $171 → $170 | Maintains | Outperform | |||
10/25/2024 | 1.04% | Baird | $85 → $79 | Maintains | Neutral | |||
10/08/2024 | 40.68% | Wells Fargo | $100 → $110 | Maintains | Equal-Weight | |||
08/28/2024 | 117.42% | Evercore ISI Group | $190 → $170 | Maintains | Outperform | |||
08/19/2024 | -0.24% | JP Morgan | $115 → $78 | Maintains | Neutral | |||
08/16/2024 | 2.31% | Deutsche Bank | $105 → $80 | Maintains | Hold | |||
08/08/2024 | 15.1% | Piper Sandler | $95 → $90 | Maintains | Underweight | |||
08/06/2024 | 8.71% | Scotiabank | $135 → $85 | Maintains | Sector Perform | |||
08/06/2024 | 41.96% | RBC Capital | $128 → $111 | Maintains | Outperform | |||
08/05/2024 | 68.82% | Keybanc | $151 → $132 | Maintains | Overweight | |||
08/05/2024 | 8.71% | Baird | $102 → $85 | Downgrade | Outperform → Neutral | |||
08/02/2024 | 61.15% | B of A Securities | $135 → $126 | Maintains | Buy | |||
08/02/2024 | 30.45% | Baird | $127 → $102 | Maintains | Outperform | |||
07/31/2024 | 6.15% | Berenberg | $160 → $83 | Downgrade | Buy → Hold | |||
07/18/2024 | 34.29% | Deutsche Bank | $140 → $105 | Maintains | Hold | |||
07/17/2024 | 21.5% | HSBC | → $95 | Downgrade | Buy → Hold | |||
07/12/2024 | 27.89% | Citigroup | $137 → $100 | Maintains | Neutral | |||
07/11/2024 | 27.89% | Wells Fargo | $145 → $100 | Downgrade | Overweight → Equal-Weight | |||
07/10/2024 | 93.12% | Keybanc | $159 → $151 | Maintains | Overweight | |||
07/09/2024 | 39.4% | UBS | $124 → $109 | Maintains | Neutral | |||
07/09/2024 | 127.65% | Oppenheimer | $188 → $178 | Maintains | Outperform | |||
07/09/2024 | 62.42% | Baird | $170 → $127 | Maintains | Outperform | |||
06/25/2024 | 21.5% | Piper Sandler | $122 → $95 | Maintains | Underweight | |||
06/13/2024 | 58.59% | UBS | $132 → $124 | Maintains | Neutral | |||
05/24/2024 | 100.79% | RBC Capital | $157 → $157 | Reiterates | Outperform → Outperform | |||
05/21/2024 | 72.66% | Scotiabank | $150 → $135 | Downgrade | Sector Outperform → Sector Perform | |||
05/07/2024 | 79.05% | Deutsche Bank | $125 → $140 | Maintains | Hold | |||
05/06/2024 | 91.84% | Scotiabank | $160 → $150 | Maintains | Sector Outperform | |||
05/06/2024 | 100.79% | RBC Capital | $138 → $157 | Maintains | Outperform | |||
05/02/2024 | 63.7% | Mizuho | $112 → $128 | Maintains | Neutral | |||
04/11/2024 | 85.45% | Wells Fargo | $135 → $145 | Maintains | Overweight | |||
04/11/2024 | 104.63% | Berenberg | $130 → $160 | Upgrade | Hold → Buy | |||
04/10/2024 | 72.66% | Citigroup | $125 → $135 | Maintains | Neutral | |||
04/10/2024 | 99.51% | B of A Securities | $137 → $156 | Upgrade | Neutral → Buy | |||
03/15/2024 | 107.19% | Loop Capital | $168 → $162 | Maintains | Buy | |||
03/11/2024 | 3.59% | Morgan Stanley | $90 → $81 | Maintains | Underweight | |||
03/08/2024 | 85.45% | Vertical Research | → $145 | Downgrade | Buy → Hold | |||
03/07/2024 | 43.24% | Mizuho | $115 → $112 | Maintains | Neutral | |||
03/07/2024 | 103.35% | Keybanc | $178 → $159 | Maintains | Overweight | |||
03/01/2024 | — | Wolfe Research | — | Initiates | → Peer Perform | |||
02/27/2024 | 47.08% | Mizuho | $105 → $115 | Maintains | Neutral | |||
02/16/2024 | 72.66% | Wells Fargo | $140 → $135 | Maintains | Overweight | |||
02/16/2024 | 76.49% | RBC Capital | $140 → $138 | Maintains | Outperform | |||
02/16/2024 | 140.44% | Oppenheimer | $191 → $188 | Maintains | Outperform | |||
02/16/2024 | 127.65% | Keybanc | $199 → $178 | Maintains | Overweight | |||
02/15/2024 | 59.87% | UBS | $137 → $125 | Maintains | Neutral | |||
02/09/2024 | 53.47% | Citigroup | $175 → $120 | Downgrade | Buy → Neutral | |||
01/30/2024 | 75.21% | UBS | $142 → $137 | Maintains | Neutral | |||
01/29/2024 | 66.26% | TD Cowen | → $130 | Downgrade | Outperform → Market Perform | |||
01/23/2024 | 66.26% | Mizuho | $152 → $130 | Maintains | Neutral | |||
01/17/2024 | 144.28% | Oppenheimer | $308 → $191 | Maintains | Outperform | |||
01/11/2024 | 81.61% | UBS | $130 → $142 | Maintains | Neutral | |||
01/11/2024 | 72.66% | Deutsche Bank | $155 → $135 | Downgrade | Buy → Hold | |||
01/09/2024 | 154.51% | Keybanc | $200 → $199 | Maintains | Overweight | |||
12/21/2023 | 123.81% | Citigroup | $170 → $175 | Maintains | Buy | |||
12/12/2023 | 90.56% | B of A Securities | $154 → $149 | Upgrade | Underperform → Neutral | |||
12/05/2023 | 63.7% | Piper Sandler | $140 → $128 | Downgrade | Neutral → Underweight | |||
11/07/2023 | 130.21% | BMO Capital | $265 → $180 | Maintains | Outperform | |||
11/06/2023 | 108.47% | RBC Capital | $212 → $163 | Maintains | Outperform | |||
11/06/2023 | 79.05% | UBS | $253 → $140 | Downgrade | Buy → Neutral | |||
11/03/2023 | 293.91% | Oppenheimer | $344 → $308 | Maintains | Outperform | |||
11/03/2023 | 155.79% | Keybanc | $254 → $200 | Maintains | Overweight | |||
10/25/2023 | 98.24% | Piper Sandler | $255 → $155 | Downgrade | Overweight → Neutral | |||
10/18/2023 | 105.91% | B of A Securities | $212 → $161 | Downgrade | Neutral → Underperform | |||
10/09/2023 | 232.52% | RBC Capital | → $260 | Reiterates | Outperform → Outperform | |||
10/09/2023 | 168.58% | Wells Fargo | $260 → $210 | Maintains | Overweight | |||
10/04/2023 | 174.97% | Citigroup | $265 → $215 | Maintains | Buy | |||
10/03/2023 | 224.85% | Keybanc | $291 → $254 | Maintains | Overweight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Albemarle (ALB)?
El último precio objetivo de Albemarle (NYSE:ALB) fue comunicado por Scotiabank el agosto 1, 2025. La firma de analistas fijó un precio objetivo para $70.00 que espera ALB a fall dentro de 12 meses (un posible -10.47% downside). 38 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Albemarle (ALB)?
La última calificación de analistas para Albemarle (NYSE:ALB) fue proporcionada por Scotiabank, y Albemarle mantuvo su sector perform calificación.
¿Cuándo se produjo la última revisión al alza de Albemarle (ALB)?
La última revisión al alza de Albemarle Corp se produjo en abril 11, 2024, cuando Berenberg elevó su precio objetivo a $160. Berenberg anteriormente tenía a hold para Albemarle Corp.
¿Cuándo fue la última revisión a la baja de Albemarle (ALB)?
La última revisión a la baja de Albemarle Corp se produjo en julio 30, 2025, cuando Keybanc cambió su precio objetivo de N/A a N/A para Albemarle Corp.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Albemarle (ALB)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Albemarle, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Albemarle se registró el agosto 1, 2025, por lo que la próxima calificación estará disponible en torno al agosto 1, 2026.
¿Es correcta la calificación de los analistas sobre Albemarle (ALB)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Albemarle (ALB) fue un mantuvo con un precio objetivo de $65.00 a $70.00. El precio actual al que cotiza Albemarle (ALB) es de $78.19, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.